Comprehensive genomic profiles of small cell lung cancer

Nature

Volumn 524, Issue 7563, 2015, Pages 47-53

  George, Julie ^a   Lim, Jing Shan ^b   Jang, Se Jin ^c   Cun, Yupeng ^a   Ozretia, Luka ^d   Kong, Gu ^e   Leenders, Frauke ^a   Lu, Xin ^a   Fernández Cuesta, Lynnette ^a   Bosco, Graziella ^a   Müller, Christian ^a   Dahmen, Ilona ^a   Jahchan, Nadine S ^b   Park, Kwon Sik ^b   Yang, Dian ^b   Karnezis, Anthony N ^f   Vaka, Dedeepya ^b   Torres, Angela ^b   Wang, Maia Segura ^g   Korbel, Jan O ^g   Menon, Roopika ^h   Chun, Sung Min ^c   Kim, Deokhoon ^c   Wilkerson, Matt ⁱ   Hayes, Neil ⁱ   Engelmann, David ^j   Pützer, Brigitte ^j   Bos, Marc ^a   Michels, Sebastian ^d   Vlasic, Ignacija ^d   Seidel, Danila ^a   Pinther, Berit ^a   Schaub, Philipp ^a   Becker, Christian ^k   Altmüller, Janine ^d,k   Yokota, Jun ^l,m   Kohno, Takashi ^l   Iwakawa, Reika ^l   Tsuta, Koji ⁿ   Noguchi, Masayuki ^o   Muley, Thomas ^p,q   Hoffmann, Hans ^p   Schnabel, Philipp A ^q,r   Petersen, Iver ^s   Chen, Yuan ^s   Soltermann, Alex ^t   Tischler, Verena ^t   Choi, Chang Min ^u   Kim, Yong Hee ^v   Massion, Pierre P ^w   Zou, Yong ^w   Jovanovic, Dragana ^x   Kontic, Milica ^y   Wright, Gavin M ^v   Russell, Prudence A ^y   Solomon, Benjamin ^z   Koch, Ina ^aa   Lindner, Michael ^aa   Muscarella, Lucia A ^ab   La Torre, Annamaria ^ab   Field, John K ^ac   Jakopovic, Marko ^ad   Knezevic, Jelena ^ae   Castaños Vélez, Esmeralda ^af   Roz, Luca ^ag   Pastorino, Ugo ^ag   Brustugun, Odd Terje ^ah,ai   Lund Iversen, Marius ^ai   Thunnissen, Erik ^aj   Köhler, Jens ^ak,al   Schuler, Martin ^ak,al   Botling, Johan ^am   Sandelin, Martin ^am   Sanchez Cespedes, Montserrat ^an   Salvesen, Helga B ^ao,ap   Achter, Viktor ^a   Lang, Ulrich ^a   Bogus, Magdalena ^a   Schneider, Peter M ^a   Zander, Thomas ^d   Ansén, Sascha ^d   Hallek, Michael ^a,d   Wolf, Jürgen ^d   Vingron, Martin ^aq   Yatabe, Yasushi ^ar   Travis, William D ^as,at,au   Nürnberg, Peter ^a,k   Reinhardt, Christian ^d   Perner, Sven ^d   Heukamp, Lukas ^d   Büttner, Reinhard ^aq   Haas, Stefan A ^at   Brambilla, Elisabeth ^a   Peifer, Martin ^b   Sage, Julien ^a,d   Thomas, Roman K ^a,d   more..

^a UNIVERSITY OF COLOGNE   (Germany)

^b STANFORD UNIVERSITY   (United States)

^c University of Ulsan College of Medicine   (South Korea)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^e Hanyang University   (South Korea)

^f VANCOUVER GENERAL HOSPITAL   (Canada)

^g EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^h UNIVERSITY HOSPITAL BONN   (Germany)

ⁱ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^j ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^k UNIVERSITY OF COLOGNE   (Germany)

^l NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^m Institute of Predictive and Personalized Medicine of Cancer IMPPC   (Spain)

ⁿ NATIONAL CANCER CENTER HOSPITAL   (Japan)

^o UNIVERSITY OF TSUKUBA   (Japan)

^p UNIVERSITY OF HEIDELBERG   (Germany)

^q Member of the German Center for Lung Research   (Germany)

^r UNIVERSITY OF HEIDELBERG   (Germany)

^s JENA UNIVERSITY HOSPITAL   (Germany)

^t UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^u Department of Nuclear Medicine   (South Korea)

^v University of Ulsan   (South Korea)

^w VANDERBILT INGRAM CANCER CENTER   (United States)

^x CLINICAL CENTER OF SERBIA   (Serbia)

^y ST VINCENT S HOSPITAL   (Australia)

^z PETER MACCALLUM CANCER CENTRE   (Australia)

^aa Asklepios Biobank Fur Lungenerkrankungen Comprehensive Pneumology Center Munich Member of the GermanCenter for Lung Research (DZL)   (Germany)

^ab CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^ac UNIVERSITY OF LIVERPOOL   (United Kingdom)

^ad KBC Zagreb   (Croatia)

^ae RUDER BO KOVI INSTITUTE   (Croatia)

^af CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^ag NATIONAL CANCER INSTITUTE   (Italy)

^ah UNIVERSITY OF OSLO   (Norway)

^ai OSLO UNIVERSITY HOSPITAL   (Norway)

^aj VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^ak UNIVERSITY HOSPITAL ESSEN   (Germany)

^al GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^am UPPSALA UNIVERSITY   (Sweden)

^an BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^ao UNIVERSITY OF BERGEN   (Norway)

^ap HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^aq MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^ar AICHI CANCER CENTER HOSPITAL   (Japan)

^as MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^at GRENOBLE UNIVERSITY HOSPITAL   (France)

^au INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; RB1 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CYCLIN D1; DNA BINDING PROTEIN; NOTCH RECEPTOR; NUCLEAR PROTEIN; P73 PROTEIN, HUMAN; RETINOBLASTOMA PROTEIN; TP53 PROTEIN, HUMAN; TRP73 PROTEIN, MOUSE; TUMOR PROTEIN P73;

CANCER; CELLS AND CELL COMPONENTS; GENOME; RESPIRATORY DISEASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYCLIN D1 GENE; EXPERIMENTAL MODEL; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE REARRANGEMENT; GENOME; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUSE; MULTIGENE FAMILY; MUTANT; NONHUMAN; PRIORITY JOURNAL; SMALL CELL LUNG CANCER; WILD TYPE; ALLELE; ANIMAL; CHROMOSOME BREAKAGE; DISEASE MODEL; GENE EXPRESSION PROFILING; GENETICS; GENOMICS; HUMAN GENOME; LUNG TUMOR; METABOLISM; MUTATION; NEUROSECRETION; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

MUS;

ALLELES; ANIMALS; CELL LINE, TUMOR; CHROMOSOME BREAKPOINTS; CYCLIN D1; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENOME, HUMAN; GENOMICS; HUMANS; LUNG NEOPLASMS; MALE; MICE; MUTATION; NEUROSECRETORY SYSTEMS; NUCLEAR PROTEINS; RECEPTORS, NOTCH; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; SMALL CELL LUNG CARCINOMA; TUMOR PROTEIN P73; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84938132350     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature14664     Document Type: Article

References (50)

1. van Meerbeeck, J. P., Fennell, D. A. & De Ruysscher, D. K. Small-cell lung cancer. Lancet 378, 1741-1755 (2011
2. Peifer, M. et al. Integrative genome analyses identify key somatic drivermutations of small-cell lung cancer. Nature Genet. 44, 1104-1110 (2012
3. Rudin, C. M. et al.Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nature Genet. 44, 1111-1116 (2012
4. Takahashi, T. et al. p53: a frequent target for genetic abnormalities in lung cancer. Science 246, 491-494 (1989
5. Wistuba, I. I., Gazdar, A. F. & Minna, J. D. Molecular genetics of small cell lung carcinoma. Semin. Oncol. 28, 3-13 (2001
6. Horowitz, J. M. et al. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc. Natl Acad. Sci. USA 87, 2775-2779 (1990
7. Mori, N. et al. Variable mutations of the RB gene in small-cell lung carcinoma. Oncogene 5, 1713-1717 (1990
8. Meuwissen, R. et al. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 4, 181-189 (2003
9. Schaffer, B. E. et al. Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma. Cancer Res. 70, 3877-3883 (2010
10. McFadden, D. G. et al. Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing. Cell 156, 1298-1311 (2014
11. Imielinski, M. et al. Mapping the hallmarks of lung adenocarcinomawith massively parallel sequencing. Cell 150, 1107-1120 (2012
12. Zhang, J. et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science 346, 256-259 (2014
13. de Bruin, E. C. et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science 346, 251-256 (2014
14. Futreal, P. A. et al. A census of human cancer genes. Nature Rev. Cancer 4, 177-183 (2004
15. Forbes, S. A. et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res. 43, D805-D811 (2015
16. Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-Associated genes. Nature 499, 214-218 (2013
17. Yokomizo, A. et al. PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers. Oncogene 17, 475-479 (1998
18. Holderfield, M., Deuker, M. M., McCormick, F. & McMahon, M. Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond. Nature Rev. Cancer 14, 455-467 (2014
19. Hibi, K. et al. Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer. Oncogene 6, 2291-2296 (1991
20. Hirota, S. et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279, 577-580 (1998
21. Shibata, T., Kokubu, A., Tsuta, K. & Hirohashi, S. Oncogenic mutation of PIK3CA in small cell lung carcinoma: a potential therapeutic target pathway for chemotherapy-resistant lung cancer. Cancer Lett. 283, 203-211 (2009
22. Angeloni, D. et al. Analysis of a new homozygous deletion in the tumor suppressor region at 3p12.3 reveals two novel intronic noncoding RNA genes. Genes Chromosom. Cancer 45, 676-691 (2006
23. Kovatich, A. et al. Molecular alterations to human chromosome 3p loci in neuroendocrine lung tumors. Cancer 83, 1109-1117 (1998
24. Weiss, J. et al. Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. Sci. Transl. Med. 2, 62ra93 (2010
25. Korbel, J. O. & Campbell, P. J. Criteria for inference of chromothripsis in cancer genomes. Cell 152, 1226-1236 (2013
26. Knudson, A. G. Two genetic hits (more or less) to cancer. 1, Nature Rev. Genet. 1, 157-162 (2001
27. Berger, A. H., Knudson, A. G. & Pandolfi, P. P. A continuum model for tumour suppression. Nature 476, 163-169 (2011
28. Beasley, M. B. et al. The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung. Hum. Pathol. 34, 136-142 (2003
29. Northcott, P. A. et al. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma. Nature 511, 428-434 (2014
30. The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337 (2012
31. Pitkanen, E., Cajuso, T., Katainen, R., Kaasinen, E. & Valimaki, N. Frequent L1 retrotranspositions originating from TTC28 in colorectal cancer. Oncotarget 5, 853-859 (2014
32. Helman, E., Lawrence, M. L. & Stewart, C. Somatic retrotransposition in human cancer revealed by whole-genome and exome sequencing. Genome Res. 24, 1053-1063 (2014
33. Jancalek, R. The role of the TP73 gene and its transcripts in neuro-oncology. Br. J. Neurosurg. 28, 598-605 (2014
34. Tannapfel, A. et al. Autonomous growth and hepatocarcinogenesis in transgenic mice expressing the p53 family inhibitor DNp73. Carcinogenesis 29, 211-218 (2008
35. Venkatanarayan, A. et al. IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo. Nature 517, 626-630 (2015
36. Falix, F. A., Aronson, D. C., Lamers, W. H. & Gaemers, I. C. Possible roles of DLK1 in theNotch pathway during development and disease. Biochim. Biophys. Acta 1822, 988-995 (2012
37. Ball, D. W. Achaete-scute homolog-1 and Notch in lung neuroendocrine development and cancer. Cancer Lett. 204, 159-169 (2004
38. Augustyn, A. et al. ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers. Proc. Natl Acad. Sci. USA 111, 14788-14793 (2014
39. Sriuranpong, V. et al. Notch signaling induces cell cycle arrest in small cell lung cancer cells Cancer Res. 1, 3200-3205 (2001
40. Wael, H. et al. Notch1 signaling controls cell proliferation, apoptosis and differentiation in lung carcinoma. Lung Cancer 85, 131-140 (2014
41. Rangarajan, A. et al. Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J. 20, 3427-3436 (2001
42. Qi, R. et al. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Res. 63, 8323-8329 (2003
43. Iwakawa, R. et al. Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer. Genes Chromosomes Cancer 52, 802-816 (2013
44. Seidel, D. A genomics-based classification of human lung tumors. Sci. Transl. Med. 5, 209ra153 (2013
45. Lafkas, D. et al. Notch3 marks clonogenic mammary luminal progenitor cells in vivo. J. Cell Biol. 203, 47-56 (2013
46. Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L. & Luo, L. A global doublefluorescent Cre reporter mouse. Genesis 45, 593-605 (2007
47. Lu, X., Thomas, R. K. & Peifer, M. CGARS: cancer genome analysis by rank sums. Bioinformatics 30, 1295-1296 (2014
48. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009
49. Fernandez-Cuesta, L. et al. Frequentmutations in chromatin-remodelling genes in pulmonary carcinoids. Nat. Commun. 5, 3518 (2014
50. Jahchan, N. S. et al. A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. Cancer Discov. 3, 1364-1377 (2013